CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.70% | 0.33% | -1.31% | 7.88% | 6.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.70% | 0.33% | -1.31% | 7.88% | 6.70% |
| Cost of Revenue | 1.84% | -9.67% | -4.64% | 23.83% | 10.46% |
| Gross Profit | -2.78% | 8.52% | 1.27% | -4.19% | 3.81% |
| SG&A Expenses | -0.59% | 2.40% | -7.87% | 2.26% | 5.30% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.24% | -3.39% | -4.88% | 13.69% | 7.72% |
| Operating Income | -15.80% | 29.41% | 44.24% | -24.75% | -0.62% |
| Income Before Tax | 508.68% | 4.77% | 139.25% | -32.97% | -92.43% |
| Income Tax Expenses | 339.39% | -2.61% | 176.71% | 26.57% | -81.07% |
| Earnings from Continuing Operations | 592.41% | 7.70% | 129.09% | -50.41% | -94.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 592.41% | 7.70% | 129.09% | -50.41% | -94.16% |
| EBIT | -15.80% | 29.41% | 44.24% | -24.75% | -0.62% |
| EBITDA | -9.64% | 20.73% | 26.22% | -17.27% | 0.70% |
| EPS Basic | 615.91% | 10.87% | 131.97% | -50.49% | -94.18% |
| Normalized Basic EPS | -28.78% | 52.04% | 78.97% | -27.31% | 4.47% |
| EPS Diluted | 633.33% | 11.20% | 136.84% | -49.97% | -94.27% |
| Normalized Diluted EPS | -29.04% | 52.31% | 79.87% | -26.93% | 4.99% |
| Average Basic Shares Outstanding | -3.32% | -2.84% | -1.24% | 0.15% | 0.32% |
| Average Diluted Shares Outstanding | -2.98% | -3.02% | -1.70% | -0.37% | -0.20% |
| Dividend Per Share | -- | -- | -- | -100.00% | 0.00% |
| Payout Ratio | -- | -- | -- | 1.02% | 16.21% |